for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-EMA To Meet On Thursday To Conclude On Information Gathered On Astrazeneca Vaccine And Thromboembolic Events

March 15 (Reuters) - European Medicines Agency:

* EMA SAYS SAFETY COMMITTEE CONTINUES INVESTIGATION OF COVID-19 VACCINE ASTRAZENECA AND THROMBOEMBOLIC EVENTS - FURTHER UPDATE

* EMA SAYS INVESTIGATION CONTINUING OVER WEEKEND, AND RIGOROUS ANALYSIS OF ALL DATA RELATED TO THROMBOEMBOLIC EVENTS WILL BE CARRIED OUT IN COMING DAYS

* EMA SAYS PRAC TO FURTHER REVIEW INFORMATION TOMORROW (TUESDAY) AND HAS CALLED EXTRAORDINARY MEETING ON THURSDAY 18 MARCH TO CONCLUDE ON INFORMATION GATHERED

* EMA - EVENTS INVOLVING BLOOD CLOTS, SOME WITH UNUSUAL FEATURES LIKE LOW NUMBERS OF PLATELETS, HAVE OCCURRED IN VERY SMALL NUMBER OF PEOPLE WHO RECEIVED VACCINE

* EMA - CURRENTLY REMAINS OF VIEW BENEFITS OF ASTRAZENECA VACCINE IN PREVENTING COVID-19, WITH ASSOCIATED RISK OF HOSPITALISATION & DEATH, OUTWEIGH RISKS OF SIDE EFFECTS Source text: (bit.ly/3trmufB) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up